scholarly article | Q13442814 |
P2093 | author name string | Nau H | |
Elmazar MM | |||
Bojic U | |||
Hauck RS | |||
P433 | issue | 5 | |
P921 | main subject | teratogenicity | Q56246640 |
P304 | page(s) | 866-870 | |
P577 | publication date | 1996-07-01 | |
P1433 | published in | Chemical Research in Toxicology | Q473530 |
P1476 | title | Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect | |
P478 | volume | 9 |
Q40189817 | A Flavin Analogue with Improved Solubility in Organic Solvents. |
Q36789953 | Anticonvulsant efficacy of valproate-like carboxylic acids: a potential target for anti-bipolar therapy |
Q53451403 | Design and Comparative Evaluation of the Anticonvulsant Profile, Carbonic-Anhydrate Inhibition and Teratogenicity of Novel Carbamate Derivatives of Branched Aliphatic Carboxylic Acids with 4-Aminobenzensulfonamide. |
Q64985073 | Design and pharmacological activity of glycinamide and N-methoxy amide derivatives of analogs and constitutional isomers of valproic acid. |
Q47639687 | Differential prenatal toxicity of one straight-chain and five branched-chain primary alcohols in rats |
Q40462745 | Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core struc |
Q24670430 | Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain |
Q42985549 | Influence of CYP2C9 polymorphism on metabolism of valproate and its hepatotoxin metabolite in Iranian patients |
Q34102615 | Peroxisome proliferator-activated receptor delta is a specific sensor for teratogenic valproic acid derivatives |
Q36673587 | Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: a potential drug for bipolar disorder |
Q38258233 | QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity. |
Q48335916 | Radial astrocytes: toxic effects induced by antiepileptic drug in the developing rat hippocampus in vitro |
Q28972380 | Seizure control by ketogenic diet-associated medium chain fatty acids |
Q55477468 | Studies on the teratogen pharmacophore of valproic acid analogues: evidence of interactions at a hydrophobic centre. |
Q40504360 | Synthesis and Pharmacological Evaluation of Novel Benzenesulfonamide Derivatives as Potential Anticonvulsant Agents. |
Q53612497 | Synthesis and anticonvulsant activity of ethyl 2,2-dimethyl-1-(2-substitutedhydrazinecarboxamido) cyclopropanecarboxylate derivatives. |
Q43793866 | Synthesis of valproic acid amides of a melatonin derivative, a piracetam and amantadine for biological tests |
Q36053511 | The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver |
Q39608766 | The embryonic stem cell test as tool to assess structure-dependent teratogenicity: the case of valproic acid. |
Q39570462 | The teratogenic potencies of valproic acid derivatives and their effects on biological end-points are related to changes in histone deacetylase and Erk1/2 activities. |
Q74463323 | Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid |
Q39575256 | Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle. |